HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaobin Jia Selected Research

qinpi

10/2018Research on the pharmacodynamics and mechanism of Fraxini Cortex on hyperuricemia based on the regulation of URAT1 and GLUT9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaobin Jia Research Topics

Disease

26Neoplasms (Cancer)
01/2022 - 01/2010
10Lung Neoplasms (Lung Cancer)
01/2020 - 06/2009
9Inflammation (Inflammations)
03/2022 - 03/2010
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 01/2010
5Osteoporosis
12/2019 - 11/2014
4Diabetic Nephropathies (Diabetic Nephropathy)
05/2022 - 01/2014
4Breast Neoplasms (Breast Cancer)
03/2018 - 05/2013
3Neoplasm Metastasis (Metastasis)
10/2020 - 11/2014
3Infarction (Infarctions)
01/2020 - 07/2016
2Arthritis (Polyarthritis)
03/2022 - 11/2010
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 03/2018
2Type 2 Diabetes Mellitus (MODY)
12/2020 - 01/2018
2Brain Ischemia (Cerebral Ischemia)
01/2020 - 07/2016
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 07/2017
2Body Weight (Weight, Body)
11/2014 - 07/2013
2Diabetic Angiopathies (Diabetic Angiopathy)
09/2013 - 02/2013
1Experimental Arthritis
03/2022
1Rheumatic Diseases (Rheumatism)
03/2022
1Myocardial Infarction
01/2021
1Ulcerative Colitis
01/2021
1Nephrotic Syndrome (Syndrome, Nephrotic)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
11/2020
1Colitis
07/2019
1Pulmonary Edema
01/2019
1Acute Lung Injury
01/2019
1Hyperuricemia
10/2018
1Bone Resorption
09/2018

Drug/Important Bio-Agent (IBA)

7baohuoside IIBA
12/2019 - 07/2012
7MicellesIBA
11/2017 - 01/2016
6Polysaccharides (Glycans)IBA
05/2022 - 10/2010
5Pharmaceutical PreparationsIBA
01/2021 - 01/2016
5Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2013
4FlavonoidsIBA
09/2018 - 01/2012
3moutan cortexIBA
05/2022 - 01/2014
3CytokinesIBA
03/2022 - 12/2016
3Caspase 3 (Caspase-3)IBA
01/2022 - 01/2016
3Peptides (Polypeptides)IBA
01/2021 - 01/2020
3Biological ProductsIBA
11/2020 - 05/2017
3Liposomes (Liposome)IBA
01/2020 - 09/2011
3tocophersolanIBA
01/2020 - 01/2016
3GlycosidesIBA
01/2020 - 07/2017
3LipopolysaccharidesIBA
01/2019 - 05/2016
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 05/2016
3Succinic Acid (Succinate)IBA
11/2017 - 01/2016
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
11/2017 - 01/2016
3AntioxidantsIBA
04/2014 - 12/2010
3Streptozocin (Streptozotocin)FDA Link
04/2014 - 07/2013
3Advanced Glycation End ProductsIBA
09/2013 - 02/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 03/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 01/2020
2Matrix Metalloproteinases (MMPs)IBA
10/2020 - 03/2018
2astragaloside AIBA
01/2020 - 11/2014
2epimedii flavoneIBA
12/2019 - 09/2018
2paeonolIBA
01/2019 - 07/2013
2serum P-component (CIt)IBA
09/2018 - 11/2014
2Drug CarriersIBA
07/2018 - 02/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2018 - 05/2016
2NF-kappa B (NF-kB)IBA
03/2018 - 12/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2018 - 07/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2018 - 07/2016
2Sirtuin 1IBA
01/2018 - 01/2017
2EnzymesIBA
05/2016 - 03/2010
2Oxidants (Oxidizing Agents)IBA
12/2015 - 02/2013
2SmokeIBA
12/2015 - 08/2012
1ShuangdanIBA
01/2022
1Nonprescription Drugs (Patent Medicines)IBA
01/2022
1Drug CombinationsIBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1Capsules (Microcapsules)IBA
01/2022
1HydrogelsIBA
01/2021
1salvianolic acid BIBA
01/2021
1TransglutaminasesIBA
01/2021
1GlucosidasesIBA
12/2020
1ThymosinIBA
11/2020
1MicroRNAs (MicroRNA)IBA
11/2020
1MethyltransferasesIBA
11/2020
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1ProdrugsIBA
10/2020
17,3'-dihydroxy-4'-methoxyisoflavoneIBA
01/2020
1Therapeutic UsesIBA
01/2020
1AcidsIBA
01/2020
1SolutionsIBA
01/2020
1cycloastragenolIBA
01/2020
1astragaloside IIIBA
01/2020
1formononetinIBA
01/2020
1calycosin-7-O-beta-D-glucosideIBA
01/2020
1InflammasomesIBA
07/2019
1Messenger RNA (mRNA)IBA
01/2019
1qinpiIBA
10/2018
1potassium oxonateIBA
10/2018
1Urea (Carbamide)FDA LinkGeneric
10/2018
1NitrogenIBA
10/2018
1HypoxanthineIBA
10/2018
1Uric Acid (Urate)IBA
10/2018
1CreatinineIBA
10/2018

Therapy/Procedure

5Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 07/2012
4Therapeutics
01/2022 - 06/2009
2Oral Administration
03/2022 - 04/2015
1Injections
01/2021